vs
COFFEE HOLDING CO INC(JVA)与STANDARD BIOTOOLS INC.(LAB)财务数据对比。点击上方公司名可切换其他公司
COFFEE HOLDING CO INC的季度营收约是STANDARD BIOTOOLS INC.的1.4倍($27.7M vs $19.6M),COFFEE HOLDING CO INC净利率更高(2.9% vs -177.4%,领先180.3%),COFFEE HOLDING CO INC同比增速更快(30.8% vs -11.5%),COFFEE HOLDING CO INC自由现金流更多($265.4K vs $-23.1M),过去两年COFFEE HOLDING CO INC的营收复合增速更高(19.2% vs -12.2%)
黑步枪咖啡公司是一家总部位于美国犹他州盐湖城的咖啡企业,由前美国陆军绿色贝雷帽成员埃文·黑弗于2014年创立。2017年,该公司因回应星巴克招聘一万名难民的承诺,宣布将招聘一万名退伍军人而受到全美国关注。
Standard BioTools(原Fluidigm公司)是一家美国生命科学工具企业,主营流式细胞术与组织成像分析用质谱流式系统,以及配套的检测试剂盒与试剂,同时供应自动化基因组分析仪器、各类微流控芯片(又称集成流体电路)及配套试剂耗材,全系列产品及应用场景均可提供定制检测方案与相关服务。
JVA vs LAB — 直观对比
营收规模更大
JVA
是对方的1.4倍
$19.6M
营收增速更快
JVA
高出42.3%
-11.5%
净利率更高
JVA
高出180.3%
-177.4%
自由现金流更多
JVA
多$23.4M
$-23.1M
两年增速更快
JVA
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $27.7M | $19.6M |
| 净利润 | $811.5K | $-34.7M |
| 毛利率 | 8.5% | 48.5% |
| 营业利润率 | 2.8% | -168.5% |
| 净利率 | 2.9% | -177.4% |
| 营收同比 | 30.8% | -11.5% |
| 净利润同比 | -35.7% | -28.8% |
| 每股收益(稀释后) | $0.15 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
JVA
LAB
| Q4 25 | $27.7M | — | ||
| Q3 25 | $23.9M | $19.6M | ||
| Q2 25 | $23.3M | $21.8M | ||
| Q1 25 | $21.3M | $40.8M | ||
| Q4 24 | $21.2M | — | ||
| Q3 24 | $18.8M | $22.1M | ||
| Q2 24 | $19.0M | $22.5M | ||
| Q1 24 | $19.5M | $45.5M |
净利润
JVA
LAB
| Q4 25 | $811.5K | — | ||
| Q3 25 | $-1.2M | $-34.7M | ||
| Q2 25 | $644.1K | $-33.5M | ||
| Q1 25 | $1.2M | $-26.0M | ||
| Q4 24 | $1.3M | — | ||
| Q3 24 | $626.8K | $-26.9M | ||
| Q2 24 | $-21.8K | $-45.7M | ||
| Q1 24 | $351.0K | $-32.2M |
毛利率
JVA
LAB
| Q4 25 | 8.5% | — | ||
| Q3 25 | 12.2% | 48.5% | ||
| Q2 25 | 18.9% | 48.8% | ||
| Q1 25 | 26.9% | 48.4% | ||
| Q4 24 | 23.2% | — | ||
| Q3 24 | 20.9% | 54.9% | ||
| Q2 24 | 19.5% | 46.1% | ||
| Q1 24 | 17.8% | 53.1% |
营业利润率
JVA
LAB
| Q4 25 | 2.8% | — | ||
| Q3 25 | -4.6% | -168.5% | ||
| Q2 25 | 3.8% | -118.1% | ||
| Q1 25 | 7.5% | -80.8% | ||
| Q4 24 | 8.0% | — | ||
| Q3 24 | 3.8% | -120.9% | ||
| Q2 24 | -0.4% | -134.5% | ||
| Q1 24 | 3.2% | -132.2% |
净利率
JVA
LAB
| Q4 25 | 2.9% | — | ||
| Q3 25 | -5.0% | -177.4% | ||
| Q2 25 | 2.8% | -153.7% | ||
| Q1 25 | 5.4% | -63.8% | ||
| Q4 24 | 5.9% | — | ||
| Q3 24 | 3.3% | -122.0% | ||
| Q2 24 | -0.1% | -203.3% | ||
| Q1 24 | 1.8% | -70.6% |
每股收益(稀释后)
JVA
LAB
| Q4 25 | $0.15 | — | ||
| Q3 25 | $-0.21 | $-0.09 | ||
| Q2 25 | $0.11 | $-0.09 | ||
| Q1 25 | $0.20 | $-0.07 | ||
| Q4 24 | $0.22 | — | ||
| Q3 24 | $0.11 | $-0.07 | ||
| Q2 24 | $0.00 | $-0.12 | ||
| Q1 24 | $0.06 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $701.9K | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $27.6M | $399.7M |
| 总资产 | $42.0M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
JVA
LAB
| Q4 25 | $701.9K | — | ||
| Q3 25 | $979.8K | $129.4M | ||
| Q2 25 | $1.8M | $158.6M | ||
| Q1 25 | $2.4M | $150.9M | ||
| Q4 24 | $1.4M | — | ||
| Q3 24 | $3.1M | $210.6M | ||
| Q2 24 | $2.4M | $269.8M | ||
| Q1 24 | $2.4M | $287.1M |
总债务
JVA
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益
JVA
LAB
| Q4 25 | $27.6M | — | ||
| Q3 25 | $26.8M | $399.7M | ||
| Q2 25 | $28.0M | $424.5M | ||
| Q1 25 | $27.3M | $454.6M | ||
| Q4 24 | $26.2M | — | ||
| Q3 24 | $24.9M | $489.3M | ||
| Q2 24 | $24.3M | $510.3M | ||
| Q1 24 | $24.3M | $577.3M |
总资产
JVA
LAB
| Q4 25 | $42.0M | — | ||
| Q3 25 | $45.9M | $539.6M | ||
| Q2 25 | $39.7M | $557.0M | ||
| Q1 25 | $38.9M | $579.6M | ||
| Q4 24 | $34.0M | — | ||
| Q3 24 | $33.1M | $681.5M | ||
| Q2 24 | $34.9M | $708.7M | ||
| Q1 24 | $37.6M | $777.7M |
负债/权益比
JVA
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $377.7K | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $265.4K | $-23.1M |
| 自由现金流率自由现金流/营收 | 1.0% | -118.1% |
| 资本支出强度资本支出/营收 | 0.4% | 4.5% |
| 现金转化率经营现金流/净利润 | 0.47× | — |
| 过去12个月自由现金流最近4个季度 | $-5.2M | $-111.1M |
8季度趋势,按日历期对齐
经营现金流
JVA
LAB
| Q4 25 | $377.7K | — | ||
| Q3 25 | $-3.8M | $-22.2M | ||
| Q2 25 | $-1.2M | $-20.7M | ||
| Q1 25 | $-401.9K | $-30.3M | ||
| Q4 24 | $222.0K | — | ||
| Q3 24 | $1.8M | $-27.9M | ||
| Q2 24 | $-1.2M | $-39.0M | ||
| Q1 24 | $4.6M | $-62.5M |
自由现金流
JVA
LAB
| Q4 25 | $265.4K | — | ||
| Q3 25 | $-3.9M | $-23.1M | ||
| Q2 25 | $-1.2M | $-22.6M | ||
| Q1 25 | $-419.8K | $-35.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $1.8M | $-30.1M | ||
| Q2 24 | — | $-41.0M | ||
| Q1 24 | — | $-63.3M |
自由现金流率
JVA
LAB
| Q4 25 | 1.0% | — | ||
| Q3 25 | -16.3% | -118.1% | ||
| Q2 25 | -5.0% | -103.6% | ||
| Q1 25 | -2.0% | -86.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | 9.4% | -136.4% | ||
| Q2 24 | — | -182.2% | ||
| Q1 24 | — | -138.9% |
资本支出强度
JVA
LAB
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.2% | 4.5% | ||
| Q2 25 | 0.1% | 8.7% | ||
| Q1 25 | 0.1% | 12.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.2% | 10.2% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | — | 1.7% |
现金转化率
JVA
LAB
| Q4 25 | 0.47× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.79× | — | ||
| Q1 25 | -0.35× | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | 2.90× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 13.09× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
JVA
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |